Related Experiment Video

Updated: Mar 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

979

An evaluation of high-stage cutaneous squamous cell carcinoma outcomes by sex

J Duran1, F C Morgan1, P S Karia1

  • 1Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Suite 4J, 1153 Centre Street, Boston, MA, 02130, U.S.A.

The British Journal of Dermatology
|November 29, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Related Experiment Videos

Last Updated: Mar 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

979
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

808
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
808
Skin Cancer01:30

Skin Cancer

6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K

Articles linked to this work by shared authors, journal, and citation graph.

Interactions between macro- and micro-climate: Effects on phenolic compound production in Nardus stricta at high elevations.

Plant biology (Stuttgart, Germany)·2025

Impact of malnutrition on the quality of life in older patients with advanced heart failure: a cohort study.

Revista clinica espanola·2024

Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

In-situ soil greenhouse gas fluxes under different cryptogamic covers in maritime Antarctica.

The Science of the total environment·2021

Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Association of interleukin-6 polymorphisms with obesity or metabolic traits in young Mexican-Americans.

Obesity science & practice·2018

Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.

The British journal of dermatology·2026

Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).

The British journal of dermatology·2026

Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.

The British journal of dermatology·2026

Incidence, prevalence, and life expectancy of patients with generalised pustular psoriasis in England: a population-based cohort study exploring ethnic and sex variations.

The British journal of dermatology·2026

Determinants of real-world sunscreen effectiveness: from ultraviolet radiation photobiology to human behaviour.

The British journal of dermatology·2026

Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study.

The British journal of dermatology·2026

Serum small extracellular vesicle-associated snoRNA panel adds diagnostic value to CEA and CYFRA21-1 for non-small cell lung cancer: an exploratory single-center study.

Frontiers in oncology·2026

The value of machine learning models in predicting lung metastasis in papillary thyroid carcinoma.

Frontiers in endocrinology·2026

Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.

In silico pharmacology·2026

Development and temporal validation of preoperative and combined preoperative-pathological models for lymph node metastasis in early gastric cancer.

Frontiers in oncology·2026

Other primary malignancies are associated with inferior survival in multiple myeloma: a single-center matched retrospective cohort study.

Frontiers in oncology·2026

Externally validated explainable machine learning for postoperative recurrence prediction in early-stage NSCLC.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us